Toll Brothers has staged a sharp reversal since its post-earnings low, with the stock up 11% on the week to $137.85 — but the positioning story is more complicated than a simple short squeeze.
The clearest development this week is the price recovery itself. At its worst, TOL was down 15% on the month and trading near 15-month lows, as flagged in earlier notes here. The stock has now clawed back most of that damage in a single week. Close peers moved, but by considerably less: PHM gained 5.4%, DHI rose 5.9%, and KBH added 7.8%. TOL's 11% move dwarfs the peer pack — a sign that the post-earnings selloff had gone too far, or that short covering amplified the bounce.
Short interest tells a nuanced story. Bears have trimmed positions, with SI down about 5.6% week-on-week to 3.9% of the free float — meaningful, but not a full unwind. The more striking context is the one-month picture: even after this week's covering, short interest is still 22% higher than it was 30 days ago. That residual positioning means shorts haven't abandoned the thesis, just harvested profits on the move down. The borrow market offers no squeeze pressure to force further covering. Availability is extraordinarily loose — roughly 61 times the current short interest, with around 92 million shares available to borrow versus just 3.7 million shorted. The cost to borrow has drifted lower to 0.30%, down 14% on the week and nearly 30% over the month. This is one of the cheapest and most accessible borrows in the sector.
Options positioning has eased alongside the price recovery. The put/call ratio is at 1.22, slightly below its 20-day average of 1.25 and well off the April highs near 1.31. The z-score of -0.46 confirms the defensive tilt has faded. What's notable here is the contrast with the pre-earnings setup, when the PCR was running consistently above 1.28: the hedging demand that characterised that period has dissipated, at least for now.
The Street reacted to the earnings print in mixed but generally constructive fashion. Analyst activity on May 21 — the first trading day after the results — saw most firms maintain positive ratings while revising targets. Evercore ISI raised its target to $185, citing continued outperform conviction. UBS and Truist trimmed theirs, to $187 and $165 respectively, both holding Buy ratings. RBC cut modestly to $158 but kept Outperform. The mean consensus target is $163.81, roughly 19% above the current price. One outlier: Barclays maintains Underweight with a $115 target — the sole bearish voice among active coverage. On valuation, TOL trades at a P/E of 10.3x and an EV/EBITDA of 7.9x, both low for a luxury homebuilder with a five-year EBIT CAGR above 15%. The price-to-book is 1.4x, having compressed about 8% over the past month despite the week's bounce.
The institutional ownership picture adds context. BlackRock is the largest holder at 10.6% of shares. Greenhaven Associates, a value-oriented active manager, holds 6% and added to its position in Q1. Jennison Associates recently added around 328,000 shares, making it one of the more significant recent buyers among named holders. On the insider side, the most recent activity on record is a modest April 15 sale by an independent director — low significance. The more notable insider trade was CEO Douglas Yearley's combined sale of roughly 72,000 shares across two February transactions at prices around $159-161, well above today's level. Those were disclosed planned sales at the time, but the price gap to current levels is a data point the market will note.
The earnings reaction itself is the clearest historical marker available. TOL rose 7.4% the day after the Q2 report on May 19 and added 8.6% over the subsequent five sessions — the bulk of this week's gains. With no next earnings date yet confirmed, the near-term catalyst calendar is open. What matters now is whether the 11% weekly bounce attracts fresh short rebuilding — given the still-elevated one-month SI and the friction-free borrow market — or whether the valuation case at 10x earnings begins to draw incremental institutional buying into a stock that, even after this week, remains 6% below where it traded a month ago.
See the live data behind this article on ORTEX.
Open TOL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
